Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)

Xuanzhu Biopharmaceutical Revenue

Xuanzhu Biopharmaceutical had revenue of 69.44M CNY in the half year ending June 30, 2026, with 333.19% growth. This brings the company's total for the last twelve months to 103.32M, up 223.31% year-over-year. In the year 2025, Xuanzhu Biopharmaceutical had annual revenue of 51.77M with 72.03% growth. That makes Xuanzhu Biopharmaceutical the 35,331st largest company in the world by revenue and 2,132nd in Hong Kong.

• Revenue (ttm): 103.32M CNY
• Revenue Growth: +223.31%
• P/S Ratio: 37.34
• Revenue / Employee: 300.35K CNY
• Employees: 344
• Market Cap: 4.45B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	51.77M	21.68M	72.03%
Dec 31, 2024	30.09M	30.07M	103,672.41%
Dec 31, 2023	29.00K	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 16, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 27, 2026

Data Sources Report a data error